BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21962758)

  • 1. Leflunomide in dermatology.
    Boyd AS
    J Am Acad Dermatol; 2012 Apr; 66(4):673-9. PubMed ID: 21962758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leflunomide--a new drug for pharmacological immunomodulation].
    Wozel G; Pfeiffer C
    Hautarzt; 2002 May; 53(5):309-15. PubMed ID: 12063741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.
    Nash P; Thaçi D; Behrens F; Falk F; Kaltwasser JP
    Dermatology; 2006; 212(3):238-49. PubMed ID: 16549920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide: dermatologic perspective.
    Sehgal VN; Verma P
    J Dermatolog Treat; 2013 Apr; 24(2):89-95. PubMed ID: 21801113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
    Fragoso YD; Brooks JB
    Expert Rev Clin Pharmacol; 2015 May; 8(3):315-20. PubMed ID: 25712857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leflunomide in the treatment of palmoplantar pustulosis.
    Melwani PM; Peñate Y; Guillermo N; Soler E; Hernández-Machín B; Borrego L
    Arch Dermatol; 2009 Nov; 145(11):1224-6. PubMed ID: 19917950
    [No Abstract]   [Full Text] [Related]  

  • 8. Is leflunomide effective in the treatment of psoriasis in a patient who is unable to benefit from standard first- and second-line therapies and needs an affordable treatment option?
    Affleck AG; Williams H
    Arch Dermatol; 2008 Dec; 144(12):1642-3. PubMed ID: 19075151
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.
    Kaltwasser JP; Nash P; Gladman D; Rosen CF; Behrens F; Jones P; Wollenhaupt J; Falk FG; Mease P;
    Arthritis Rheum; 2004 Jun; 50(6):1939-50. PubMed ID: 15188371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy.
    Knab J; Goos M; Dissemond J
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):243-6. PubMed ID: 15752303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe psoriasis and psoriatic arthritis with leflunomide.
    Reich K; Hummel KM; Beckmann I; Mössner R; Neumann C
    Br J Dermatol; 2002 Feb; 146(2):335-6. PubMed ID: 11903256
    [No Abstract]   [Full Text] [Related]  

  • 12. Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions.
    Marzano AV; Ramoni S; Del Papa N; Barbareschi M; Alessi E
    Lupus; 2008 Apr; 17(4):329-31. PubMed ID: 18413415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide: new indication. In psoriatic rheumatism: too many risks, too little efficacy.
    Prescrire Int; 2005 Aug; 14(78):123-6. PubMed ID: 16106593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide and rheumatoid arthritis: new preparation. Neither the safest nor the most effective slow-acting antirheumatic drug.
    Prescrire Int; 2001 Apr; 10(52):36-9. PubMed ID: 11718154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual overdose of leflunomide in a patient with rheumatoid arthritis.
    Kamali S; Kasapoglu E; Uysal M; Inanc M; Gul A
    Ann Pharmacother; 2004; 38(7-8):1320-1. PubMed ID: 15138298
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.
    Frieling U; Luger TA
    Clin Exp Dermatol; 2002 Oct; 27(7):562-70. PubMed ID: 12464151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide in the treatment of psoriasis: results of a phase II open trial.
    Tlacuilo-Parra JA; Guevara-Gutiérrez E; Rodríguez-Castellanos MA; Ornelas-Aguirre JM; Barba-Gómez JF; Salazar-Páramo M
    Br J Dermatol; 2004 May; 150(5):970-6. PubMed ID: 15149511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.
    Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190
    [No Abstract]   [Full Text] [Related]  

  • 19. Lupus erythematosus with leflunomide: induction or reactivation?
    Gensburger D; Kawashima M; Marotte H; Kanitakis J; Miossec P
    Ann Rheum Dis; 2005 Jan; 64(1):153-5. PubMed ID: 15608317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis in dermatology.
    Hata T; Kavanaugh A
    Clin Dermatol; 2006; 24(5):430-7. PubMed ID: 16966022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.